Skip to main content

Shiau Research Group

Life Course Epidemiology | HIV & Aging | Molecular Epidemiology | Translational Science

The Shiau Research Group investigates how biological, clinical, and social factors shape health across the life course, with a particular focus on HIV and aging. We integrate epidemiologic methods, molecular biomarkers, experimental collaborations, and real-world data to understand disease mechanisms and inform strategies for improving long-term health.


Research Areas


HIV and Health Across the Life Course

We investigate the development and progression of chronic conditions and multisystem morbidity among individuals growing up and aging with HIV, with a focus on long-term health trajectories and opportunities to promote healthy aging.


Biological Aging and Molecular Epidemiology

We integrate epigenomic and other multi-omics data with epidemiologic studies to investigate biological aging, inflammation, immune regulation, and molecular pathways underlying chronic disease.


Early-Life Exposures and Lifelong Health

We study how maternal health, perinatal HIV exposure, antiretroviral therapy, and inflammation during critical developmental periods influence child health, biological aging, and health across the lifespan.


Real-World Data and Population Health

We leverage large-scale administrative health data to investigate treatment patterns, medication use and safety, chronic conditions, and long-term health outcomes, with a focus on generating evidence to inform clinical care and improve population health.

 

Highlighted Active Funding

  • NIH/NIA RF1AG099751 (MPI: Chintan Dave and Stephanie Shiau)
    Using real-world data to inform the epidemiology of cardiometabolic conditions and their treatment among older adults with HIV
    Project Period: 09/2026 – 08/2030
  • NIH/NICHD R01HD122687 (MPI: Ryan Ross and Stephanie Shiau)
    Impact of maternal integrase inhibitor use on offspring fat and bone development
    Project Period: 07/2026 – 06/2031
  • NIH/NICHD R01HD111550 (PI: Stephanie Shiau)
    Maternal inflammation in relation to offspring epigenetic aging and neurodevelopment
    Project Period: 06/2023 – 05/2027
  • NIH, NIMH, P30MH144896 (MPI: Lish Ndhlovu and Tricia Burdo)
    New York-New Jersey Center for Actionable NeuroHIV Biomarkers and Integrated Omics (NYJ-CAN-BIO)
    Role: Co-Director, Biosignature Core
    Project Period: 08/2026 – 04/2030
  • NIH/NIDA K01DA053157 (PI: Stephanie Shiau)
    Leveraging large-scale administrative claims data to evaluate prescription opioid use, risks, and outcomes in older adults living with HIV
    Project Period: 06/01/2021 – 04/30/2027

Highlighted Completed Research Funding

  • PHACS Emerging Research Pilot Award (PI: Stephanie Shiau)
    Maternal ART, maternal inflammation, and epigenetic biomarkers in children with perinatal exposure to HIV
    Project Period: 05/2024 –- 07/2025
  • NIH/NIDCR (MPI: Modupe Coker and Stephanie Shiau)
    Uncovering the Biological Link between Oral and Mental health in Adolescents Living with HIV (uBLOoM)
    Project Period: 08/2023 – 07/2026
  • NIH/NICHD R21HD104558 (PI: Stephanie Shiau)
    Leveraging NICHD DASH biospecimens to isolate the effects of HIV infection and HIV exposure on epigenetic profiles in infants
    Project Period: 09/2020 – 08/2023
  • Thrasher Research Fund, Early Career Award
    Signature maternal immune activation markers of growth and infectious morbidity in HEU children
    Project Period: 09/2019 – 08/2021